Catalyst
Slingshot members are tracking this event:
Kite Expects Initial Phase 1 ZUMA-3 Data Evaluating KTE-C19 in Adult Acute Lymphoblastic Lymphoma in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
KITE |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 04, 2016
Occurred Source:
https://ash.confex.com/ash/2016/webprogram/Paper90759.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Zuma-3, Kte-c19, Aggressive Non-hodgkin Lymphoma